-
Intravenous Cefazedone PK/PD in Community-Acquired Pneumonia
2026-09-08
This open-label clinical study evaluated whether intravenous Cefazedone sodium at 2 g every 12 hours provides an appropriate pharmacokinetic and pharmacodynamic exposure in adults with mild to moderate community-acquired pneumonia. The reported time above the minimum inhibitory concentration, together with clinical and microbiological outcomes, supports the regimen for infections caused by susceptible organisms while highlighting the value of integrating PK/PD with antibacterial testing in vitro.
-
Intravenous Cefazedone PK/PD in Community-Acquired Pneumonia
2026-09-07
This clinical pharmacokinetic/pharmacodynamic study evaluated whether intravenous Cefazedone exposure was adequate for adults with mild to moderate community-acquired pneumonia. By combining plasma pharmacokinetics, pathogen susceptibility testing, and clinical outcomes, it provides a practical framework for interpreting time-dependent cephalosporin activity in patients.
-
D-N-Acetylgalactosamine: Lab Workflow Guide
2026-09-05
D-N-Acetylgalactosamine (SKU B7904) provides a defined, high-purity carbohydrate metabolite for aqueous or DMSO-based studies of glycoprotein composition, brain heteropolysaccharides, and related glycosylation workflows. It is unsuitable for ethanol-based preparation and should not be maintained as a long-term stored solution.
-
Biotin Workflows for Labeling and Motor Assays
2026-09-05
Use Biotin and Vitamin B7 strategically across protein labeling, reconstituted kinesin transport, and carboxylase-linked metabolism studies. This guide separates free biotin from covalent labeling reagents and translates BicD–MAP7 findings into practical assay controls, optimization steps, and troubleshooting decisions.
-
TMEM16F in Kupffer Cells Protects Against Listeria
2026-09-04
This study identifies Kupffer cell-expressed TMEM16F as a key determinant of host protection during Listeria monocytogenes infection, extending membrane-repair biology beyond lymphocytes. Cell-specific mouse models show that TMEM16F preserves Kupffer cell integrity while limiting liver inflammation and metabolic disruption, providing a framework for separating physical membrane injury from downstream inflammatory signaling.
-
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-09-04
Build a more reproducible fluorescence-based transfection control with a capped, modified, polyadenylated mRNA reporter. This guide connects practical mammalian-cell workflows with delivery-system considerations from current LNP research, helping teams distinguish transfection failure from translation, toxicity, or innate immune effects.
-
ORM2–ZG16 Autophagy Axis in Pancreatic Fibrosis
2026-09-03
A 2026 Pancreatology study identifies ORM2 as an endogenous suppressor of chronic pancreatitis-associated fibrosis and connects its activity to ZG16-dependent regulation of autophagy in pancreatic stellate cells. The work combines pancreas-specific genetic manipulation, cellular fibrosis models, autophagy-flux assays, and protein-interaction analysis to define a mechanistic pathway with potential value for preclinical antifibrotic research.
-
Aztreonam Workflows for Gram-Negative Research
2026-09-03
Build mechanism-aware susceptibility and resistance workflows around Aztreonam, from stock preparation and MIC testing to plasmid-context analysis. The approach also supports carefully separated exploratory assays for bone marrow progenitor cells and hepatic drug-metabolism research.
-
JXY, TLR4, and Macrophages in Colitis-Associated CRC
2026-09-02
Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. The study is notable for connecting tumor burden, macrophage function, molecular markers, and pathway-antagonism experiments in one preclinical framework.
-
GPC3-HSP70 mRNA Nanovaccine in HCC
2026-09-02
The reference study develops an SP94-targeted mRNA nanovaccine encoding tandem GPC3127–136 CTL epitopes fused to HSP70 and shows that it enhances antigen-specific T-cell responses against hepatocellular carcinoma. Combining this construct with anti-PD-L1 therapy produced stronger antitumor activity, highlighting how antigen design, intracellular delivery, and checkpoint blockade can be integrated in a preclinical vaccine strategy.
-
Levofloxacin for Reliable Cell Assays
2026-09-01
Learn how Levofloxacin (SKU B1959) can support controlled antibacterial, osteoblast, and chondrocyte experiments. This scenario-driven guide covers solvent compatibility, exposure design, calcium-deposition readouts, and practical reagent selection.
-
Methicillin Sodium Salt for MSSA Research
2026-08-31
Build reproducible MSSA susceptibility, cell-wall, and resistance assays with Methicillin sodium salt. This practical guide connects concentration-controlled workflows to the paired microbiology and susceptibility logic demonstrated in a phase 2 antibiotic study.
-
Azilsartan: A Causal Lens on AT1 Signaling
2026-08-31
Azilsartan (TAK-536) enables selective interrogation of AT1-driven signaling across cardiovascular and neuroinflammatory models. This guide focuses on causal assay design, compartment-aware interpretation, and how the gastrodin–RAS–SIRT3 study informs experiments in reactive astrocytes and microglia.
-
VE-821 ATR Kinase Inhibitor: Applied Workflows
2026-08-30
VE-821 is a selective ATR kinase inhibitor for connecting ATR–Chk1 checkpoint signaling with DNA damage, radiation, and chemotherapy response. This practical guide outlines assay setup, combination-testing logic, and troubleshooting while distinguishing established DDR applications from emerging antiviral questions.
-
APOE, M2 Macrophages, and PTC Progression
2026-08-29
This study identifies APOE as a tumor-associated regulator linking papillary thyroid carcinoma cells with M2-like macrophage polarization. Its combined tissue, co-culture, signaling, and xenograft evidence suggests that APOE-driven PI3K/Akt/NF-κB activity and IL-10 production may connect tumor progression with immune remodeling.